278 related articles for article (PubMed ID: 27938993)
1. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
[TBL] [Abstract][Full Text] [Related]
2. Sinonasal malignancies with neuroendocrine differentiation: case series and review of literature.
Menon S; Pai P; Sengar M; Aggarwal JP; Kane SV
Indian J Pathol Microbiol; 2010; 53(1):28-34. PubMed ID: 20090218
[TBL] [Abstract][Full Text] [Related]
3. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies.
Choi KY; Amit M; Tam S; Bell D; Phan J; Garden AS; Williams MD; Ferrarotto R; El-Naggar AK; Raza SM; DeMonte F; Kupferman ME; Hanna EY; Su SY
Laryngoscope; 2021 May; 131(5):E1468-E1475. PubMed ID: 32946597
[TBL] [Abstract][Full Text] [Related]
4. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
Kuo P; Manes RP; Schwam ZG; Judson BL
Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
[TBL] [Abstract][Full Text] [Related]
5. Sinonasal neuroendocrine carcinoma: a population-based analysis of incidence and survival.
Patel TD; Vazquez A; Dubal PM; Baredes S; Liu JK; Eloy JA
Int Forum Allergy Rhinol; 2015 May; 5(5):448-53. PubMed ID: 25727332
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma.
Abdelmeguid AS; Bell D; Hanna EY
Adv Otorhinolaryngol; 2020; 84():168-184. PubMed ID: 32731236
[TBL] [Abstract][Full Text] [Related]
7. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.
Mehta GU; Raza SM; Su SY; Hanna EY; DeMonte F
J Neurooncol; 2020 Dec; 150(3):367-375. PubMed ID: 32424573
[TBL] [Abstract][Full Text] [Related]
8. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
Rosenthal DI; Barker JL; El-Naggar AK; Glisson BS; Kies MS; Diaz EM; Clayman GL; Demonte F; Selek U; Morrison WH; Ang KK; Chao KS; Garden AS
Cancer; 2004 Dec; 101(11):2567-73. PubMed ID: 15517582
[TBL] [Abstract][Full Text] [Related]
9. The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma.
van der Laan TP; Bij HP; van Hemel BM; Plaat BE; Wedman J; van der Laan BF; Halmos GB
Eur Arch Otorhinolaryngol; 2013 Sep; 270(9):2565-8. PubMed ID: 23740425
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis.
Ejaz A; Wenig BM
Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
[TBL] [Abstract][Full Text] [Related]
12. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases.
van der Laan TP; Plaat BE; van der Laan BF; Halmos GB
Head Neck; 2015 May; 37(5):707-15. PubMed ID: 24596175
[TBL] [Abstract][Full Text] [Related]
13. Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers.
Bell D; Hanna EY
Expert Rev Anticancer Ther; 2013 Mar; 13(3):285-96. PubMed ID: 23477516
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
[TBL] [Abstract][Full Text] [Related]
15. A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma.
Smith SR; Som P; Fahmy A; Lawson W; Sacks S; Brandwein M
Laryngoscope; 2000 Oct; 110(10 Pt 1):1617-22. PubMed ID: 11037813
[TBL] [Abstract][Full Text] [Related]
16. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis.
Morand GB; Anderegg N; Vital D; Ikenberg K; Huber GF; Soyka MB; Egger M; Holzmann D
Oral Oncol; 2017 Dec; 75():28-34. PubMed ID: 29224819
[TBL] [Abstract][Full Text] [Related]
17. Small cell carcinoma of the head and neck: A comparative study by primary site based on population data.
Kuan EC; Alonso JE; Tajudeen BA; Arshi A; Mallen-St Clair J; St John MA
Laryngoscope; 2017 Aug; 127(8):1785-1790. PubMed ID: 27859290
[TBL] [Abstract][Full Text] [Related]
18. SMARCA4-deficient Sinonasal Carcinoma.
Agaimy A; Weichert W
Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
[TBL] [Abstract][Full Text] [Related]
19. Oncologic management of sinonasal undifferentiated carcinoma.
Tyler MA; Holmes B; Patel ZM
Curr Opin Otolaryngol Head Neck Surg; 2019 Feb; 27(1):59-66. PubMed ID: 30507692
[TBL] [Abstract][Full Text] [Related]
20. Genetic profiling of poorly differentiated sinonasal tumours.
López-Hernández A; Vivanco B; Franchi A; Bloemena E; Cabal VN; Potes S; Riobello C; García-Inclán C; López F; Llorente JL; Hermsen M
Sci Rep; 2018 Mar; 8(1):3998. PubMed ID: 29507386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
